US3906031A
(en)
|
1971-03-15 |
1975-09-16 |
Research Corp |
Novel 9-fluorenylmethoxycarbonyl compounds
|
US3835175A
(en)
|
1971-03-15 |
1974-09-10 |
Research Corp |
9-fluorenylmethanol haloformates, carbonates and thiocarbonates
|
US4108846A
(en)
|
1977-02-01 |
1978-08-22 |
Hoffmann-La Roche Inc. |
Solid phase synthesis with base N alpha-protecting group cleavage
|
DE3542442A1
(de)
|
1985-11-30 |
1987-06-04 |
Hoechst Ag |
Verfahren zur herstellung von peptiden unter der verwendung von perchloraten
|
US5175254A
(en)
|
1988-09-24 |
1992-12-29 |
Societe D'expansion Scientifque Expansia |
Solid phase peptide synthesis using a polyacrylic support in aqueous solution
|
GB8913089D0
(en)
|
1989-06-07 |
1989-07-26 |
Ciba Geigy Japan Ltd |
Novel endothelin derivative
|
US5296468A
(en)
|
1989-10-30 |
1994-03-22 |
The Salk Institute For Biological Studies |
GnRH analogs
|
US5580957A
(en)
|
1989-10-30 |
1996-12-03 |
The Salk Institute For Biological Studies |
GnRH analogs
|
US5352796A
(en)
|
1989-10-30 |
1994-10-04 |
The Salk Institute For Biological Studies |
Amino acids useful in making GnRH analogs
|
US5169932A
(en)
|
1989-10-30 |
1992-12-08 |
The Salk Institute For Biological Studies |
Gnrh analogs
|
EP0445801A3
(en)
|
1990-03-08 |
1992-07-01 |
Kuraray Co., Ltd. |
Peptide and its use
|
IT1241395B
(it)
|
1990-04-02 |
1994-01-10 |
Eniricerche Spa |
Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
|
DE4014655A1
(de)
|
1990-05-08 |
1991-11-14 |
Behringwerke Ag |
Peptidamide, verfahren zu deren herstellung und diese enthaltende mittel als fibrin/thrombin-gerinnungsinhibitoren
|
TW295589B
(es)
|
1990-08-30 |
1997-01-11 |
Hoechst Ag |
|
DE4027675C2
(de)
|
1990-08-31 |
1997-05-07 |
Biotechnolog Forschung Gmbh |
Verfahren zur parallelen Herstellung von trägergebundenen oder freien Peptiden, trägergebundene Peptide und ihre Verwendung
|
IL101074A
(en)
|
1991-03-14 |
1997-09-30 |
Salk Inst For Biological Studi |
GnRH ANALOGS AND THEIR PREPARATION
|
US5744450A
(en)
|
1991-03-14 |
1998-04-28 |
The Salk Institute For Biological Studies |
GnRH analogs
|
SE9101472D0
(sv)
|
1991-05-15 |
1991-05-15 |
Trion Forskning & Utveckling |
Galanin antagonist
|
US5576296A
(en)
|
1991-05-15 |
1996-11-19 |
Aktiebolaget Astra |
Galanin antagonist
|
GB9112825D0
(en)
|
1991-06-14 |
1991-07-31 |
Ici Plc |
Process for making peptides
|
JP3407260B2
(ja)
|
1991-08-09 |
2003-05-19 |
コルベツク,ヴインフリート |
ランチオニン架橋ペプチド
|
US6028168A
(en)
|
1991-08-09 |
2000-02-22 |
Winfried Kolbeck |
Lanthionine bridged peptides
|
US5639603A
(en)
|
1991-09-18 |
1997-06-17 |
Affymax Technologies N.V. |
Synthesizing and screening molecular diversity
|
CA2118806A1
(en)
|
1991-09-18 |
1993-04-01 |
William J. Dower |
Method of synthesizing diverse collections of oligomers
|
CA2104099A1
(en)
|
1991-12-18 |
1993-06-19 |
George A. Heavner |
Peptide inhibitors of inflammation mediated by selectins
|
US6709828B1
(en)
|
1992-03-06 |
2004-03-23 |
N.V. Innogenetics S.A. |
Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
|
KR20030096423A
(ko)
|
1992-03-06 |
2003-12-31 |
엔. 브이. 이노제네틱스 소시에떼아노님 |
면역학적으로 중요한 에피토프에 상응하는 펩티드의 측정방법 및 면역학적으로 중요한 에피토프에 상응하는 항체또는 비오티닐화된 펩티드의 측정 방법에 상기 펩티드를사용하는 방법, 상기 펩티드의 제조방법 및 상기 펩티드를함유하는 조성물
|
US6667387B1
(en)
|
1996-09-30 |
2003-12-23 |
N.V. Innogenetics S.A. |
HCV core peptides
|
WO1993024526A1
(en)
|
1992-05-28 |
1993-12-09 |
Centocor, Inc. |
Peptide inhibitors of selectin binding
|
IE921942A1
(en)
|
1992-06-16 |
1993-12-29 |
Gary A Siwruk John S Eynon |
Liquid phase synthesis of peptides and peptide derivatives
|
US5516891A
(en)
|
1992-06-16 |
1996-05-14 |
Kinerton, Ltd. |
Liquid phase synthesis of peptides and peptide derivatives
|
WO1994005314A1
(en)
|
1992-09-08 |
1994-03-17 |
Centocor, Inc. |
Peptide inhibitors of leukocyte adhesion
|
US5563032A
(en)
|
1992-10-21 |
1996-10-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Mosaic polypeptide and methods for detecting the hepatitis E virus
|
US5736315A
(en)
|
1992-10-21 |
1998-04-07 |
National Institute Of Health |
Methods and compositions for detecting anti-hepatitis E virus activity
|
WO1994014836A1
(en)
|
1992-12-18 |
1994-07-07 |
Centocor, Inc. |
Peptide inhibitors of selectin binding
|
DE4244565A1
(de)
|
1992-12-30 |
1994-07-07 |
Forssmann Wolf Georg |
Verfahren und Anwendung des LPAP (Lymphocytoma Proliferation Activating Peptide
|
ES2133428T3
(es)
|
1993-02-19 |
1999-09-16 |
Hoffmann La Roche |
Fabricacion de amidas y peptidos, exenta de racemizacion, en presencia de cantidades cataliticas de un compuesto n-hidroxi.
|
JPH06256384A
(ja)
|
1993-02-26 |
1994-09-13 |
Shimadzu Corp |
クリーベイジ装置
|
GB9319776D0
(en)
|
1993-09-24 |
1993-11-10 |
Medical Res Council |
Azapeptide synthesis
|
US5503805A
(en)
|
1993-11-02 |
1996-04-02 |
Affymax Technologies N.V. |
Apparatus and method for parallel coupling reactions
|
US6165778A
(en)
|
1993-11-02 |
2000-12-26 |
Affymax Technologies N.V. |
Reaction vessel agitation apparatus
|
CN1134156A
(zh)
|
1993-11-02 |
1996-10-23 |
阿菲马克斯技术公司 |
合成和筛选多种分子
|
WO1995014787A1
(en)
|
1993-11-22 |
1995-06-01 |
Centocor, Inc. |
Peptide inhibitors of selecting binding
|
DE4341471A1
(de)
|
1993-12-02 |
1995-06-08 |
Schering Ag |
Tumor-Nekrose-Faktor-alpha-inaktivierende CDR-Peptide
|
US5502165A
(en)
|
1994-04-04 |
1996-03-26 |
Merck & Co., Inc. |
Process for peptide segment condensation
|
US5614608A
(en)
|
1995-01-20 |
1997-03-25 |
Selectide Corporation |
Apparatus and method for multiple synthesis of organic compounds on polymer support
|
AU5514396A
(en)
|
1995-04-28 |
1996-11-18 |
Takeda Chemical Industries Ltd. |
Cyclic pentapeptide lh-rh receptor antagonists
|
GB9511474D0
(en)
|
1995-06-07 |
1995-08-02 |
Ciba Geigy Ag |
Antiviral peptoid compounds
|
DE19534988A1
(de)
|
1995-09-21 |
1997-03-27 |
Forssmann Wolf Georg |
Verfahren zur Herstellung und Anwendung synthetischer, biotinylierter Peptide
|
DE19543628A1
(de)
|
1995-11-24 |
1997-05-28 |
Forssmann Wolf Georg |
Humanes, im Blut zirkulierendes Peptid mit insulinotroper Wirkung (GCAP-II-(89-112), (Guanylyl Cyclase C Aktivierendes Peptid II) und seine GCAP-Analoga, insbesondere das GCAP-I-(99-115), seine Anwendung als pharmakologischer Wirkstoff und Benutzung seines Wirkungsprinzipes zur Bereitstellung neuer GC-C-abhängiger insulinotroper Wirkstoffe
|
TW505654B
(en)
|
1996-07-30 |
2002-10-11 |
Hoffmann La Roche |
Synthesis of analogs of PTH and PTHrP
|
DK0929567T3
(da)
|
1996-09-09 |
2005-06-27 |
Zealand Pharma As |
Forbedret fastfase-peptidsyntese og middel til anvendelse af en sådan syntese
|
KR20000036015A
(ko)
|
1996-09-09 |
2000-06-26 |
스타이니스 에바 |
알파-히드록시산 링커를 함유하는 펩티드 프로드럭
|
US7176282B1
(en)
|
1996-09-09 |
2007-02-13 |
Zealand Pharma A/S |
Solid-phase peptide synthesis and agent for use in such synthesis
|
WO1998031791A1
(en)
|
1997-01-21 |
1998-07-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin |
Iga1 protease fragment as carrier peptide
|
NZ506839A
(en)
|
1998-03-09 |
2003-05-30 |
Zealand Pharma As |
Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
|
WO2000018791A1
(en)
*
|
1998-09-29 |
2000-04-06 |
Statens Serum Institut |
Ligand presenting assembly (lpa), method of preparation and uses thereof
|
JP3786533B2
(ja)
|
1998-11-12 |
2006-06-14 |
善彦 西村 |
ペプチド及び骨形成促進剤
|
IL143666A0
(en)
|
1998-12-11 |
2002-04-21 |
Coulter Pharm Inc |
Prodrug compounds and process for preparation thereof
|
US7425541B2
(en)
|
1998-12-11 |
2008-09-16 |
Medarex, Inc. |
Enzyme-cleavable prodrug compounds
|
FR2792631B1
(fr)
|
1999-04-21 |
2004-03-19 |
Pasteur Institut |
Support solide fonctionnalise pour la synthese de composes comportant au moins une fonction alpha oxoaldehyde et ses applications.
|
US6469136B1
(en)
|
1999-07-07 |
2002-10-22 |
Trimeris, Inc. |
Methods and composition for peptide synthesis
|
US6703480B1
(en)
|
1999-11-24 |
2004-03-09 |
Palani Balu |
Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use
|
FR2803594B1
(fr)
|
2000-01-11 |
2002-07-19 |
Centre Nat Rech Scient |
Oligomeres de mimes contraints non peptidiques de dipeptides ou de tripeptides, et leurs utilisations
|
DE60102899T2
(de)
|
2000-01-27 |
2005-03-31 |
Eli Lilly And Co., Indianapolis |
Verfahren zur lösung von glucagon-ähnlichen peptid-1 (glp-1) verbindungen
|
US6476186B1
(en)
|
2000-05-23 |
2002-11-05 |
Institute Of Nuclear Energy Research |
Process for preparing octreotide and derivatives thereof
|
AU7130101A
(en)
|
2000-06-14 |
2001-12-24 |
Corixa Corp |
Enzyme-cleavable prodrug compounds
|
US20020058788A1
(en)
|
2000-08-25 |
2002-05-16 |
Sheppeck James E. |
Facile deprotection of Fmoc protected amino groups
|
NO314588B1
(no)
|
2000-09-04 |
2003-04-14 |
Bionor Immuno As |
HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
|
WO2002040512A2
(de)
|
2000-11-14 |
2002-05-23 |
Ipf Pharmaceuticals Gmbh |
Humanes beta-defensin-3
|
JP2004513191A
(ja)
|
2001-01-04 |
2004-04-30 |
カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ |
ペプチドおよび小分子有機合成用の新しいリンカーに基づく固相支持体
|
GB0105069D0
(en)
|
2001-03-01 |
2001-04-18 |
Univ Ulster The |
Modified peptide
|
US20090281032A1
(en)
|
2001-03-01 |
2009-11-12 |
Peter Raymond Flatt |
Modified CCK peptides
|
BR0101088A
(pt)
|
2001-03-19 |
2003-03-18 |
Biolab Sanus Farmaceutica Ltda |
Processo de isolamento e purificação de peptìdeos inibidores das vasopeptidases, com especificidade para o sìtio carboxìlico da enzima conversora da angiotensina, secretados pelas glândulas do veneno de serpentes (bpps), particularmente bothrops jararaca, ou produzidos endogenamente (evasins) possuindo ação vasodilatadora e anti-hipertensiva; processo de determinação da sequência de amido-ácidos dos peptìdios inibidores secretados pela glândula de veneno de serpentes (bpps) ou endógenos (evasins); processo de determinação da sequência de aminoácidos dos bpps por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca. processo de determinação da sequência de aminoácidos dos evasins por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca, processo de amplificação do cdna a partir das bibliotecas de cdna de pâncreas e/ou cérebro de serpentes, especificamente bothrops jararaca; processo de sìntese em fase sólida de peptìdeos inibidores das vasopeptidases com ação vasodilatadora e anti-hipertensiva, peptìdeos inibidores das vasopeptidases com ação anti-hipertensiva; utilização dos peptìdeos inibidores das vaso peptidases com ação vasodilatadora e anti-hipertensiva na obtenção de composições farmacêuticas; processo de determinação da atividade inibitória sobre as vasopeptidases e de atividade biológica sobre músculo liso, sistema cardiovascular e microcirculatório.
|
WO2002083606A1
(en)
|
2001-04-17 |
2002-10-24 |
University Of Alberta |
A linker system for the synthesis and screening of combinatorial libraries of polyamine derivatives on water compatible supports
|
CN1162446C
(zh)
|
2001-05-10 |
2004-08-18 |
上海华谊生物技术有限公司 |
促胰岛素分泌肽衍生物
|
FR2825095B1
(fr)
|
2001-05-28 |
2003-09-26 |
Dev Des Antigenes Combinatoire |
Dispositif de presentation de polypeptides, utilisable comme "puce" pour la detection miniaturisee de molecules
|
AU2002326103A1
(en)
|
2001-08-24 |
2003-03-10 |
University Of British Columbia |
Solid-phase synthesis of oligosaccharides and glycopeptides using glycosynthases
|
EP1493747B1
(en)
|
2002-04-11 |
2012-12-19 |
Daiichi Sankyo Company, Limited |
Process for producing modified peptide
|
US6809190B2
(en)
|
2002-04-24 |
2004-10-26 |
Credia Japan Co., Ltd. |
Functional peptide nucleic acid and its production method
|
GB0210183D0
(en)
|
2002-05-03 |
2002-06-12 |
Avecia Ltd |
Process
|
WO2003093302A2
(en)
|
2002-05-03 |
2003-11-13 |
Avecia Limited |
Process for the synthesis of peptides amides by side-chain attachement to a solid phase
|
WO2003095475A2
(en)
|
2002-05-10 |
2003-11-20 |
Pharmacia Corporation |
Peptide compounds and their use as protease substrates
|
ES2195787B1
(es)
|
2002-05-20 |
2005-06-01 |
Diverdrugs, S.L. |
Compuestos capaces de bloquear la respuesta a sustancias quimicas o estimulos termicos o mediadores de la inflamacion de los nociceptores, un metodo para su obtencion y composiciones que los continen.
|
BR0313019A
(pt)
|
2002-08-09 |
2005-07-12 |
Yamanouchi Europ Bv |
Compostos que se ligam a p-selectina
|
AU2003273298B2
(en)
|
2002-09-08 |
2008-03-06 |
Applera Corporation |
Methods, compositions and libraries pertaining PNA dimer and PNA oligomer synthesis
|
CA2500295A1
(en)
*
|
2002-10-02 |
2004-04-29 |
Zealand Pharma A/S |
Stabilized exendin-4 compounds
|
EP1445260A1
(de)
|
2003-02-04 |
2004-08-11 |
Jerini AG |
Verfahren zur Immobilisierung von chemischen Verbindungen an Festphasen
|
CA2521188C
(en)
|
2003-04-08 |
2012-06-26 |
Novo Nordisk A/S |
Regeneration of chromatographic stationary phases
|
CN1771080B
(zh)
|
2003-04-08 |
2010-12-15 |
诺沃挪第克公司 |
包括至少一个色谱处理步骤的生产治疗用多肽或其前体的方法
|
WO2004092377A1
(ja)
|
2003-04-15 |
2004-10-28 |
Credia Japan Co., Ltd. |
新規な機能性ペプチド核酸およびその製法
|
EP1631597A4
(en)
|
2003-05-22 |
2007-07-11 |
Gryphon Therapeutics Inc |
SOLID PHASE CHEMICAL LIGATION CARRIED OUT WITH A MOBILE BONDING AGENT
|
WO2004105790A1
(en)
|
2003-06-03 |
2004-12-09 |
Novo Nordisk A/S |
Stabilized pharmaceutical peptide compositions
|
US7414106B2
(en)
|
2003-06-19 |
2008-08-19 |
Lawrence Livermore National Security, Llc |
Synthesis of peptide α-thioesters
|
US7902488B2
(en)
|
2003-06-23 |
2011-03-08 |
Cem Corporation |
Microwave-assisted peptide synthesis
|
US7393920B2
(en)
|
2003-06-23 |
2008-07-01 |
Cem Corporation |
Microwave-assisted peptide synthesis
|
EP1664109B1
(en)
|
2003-08-21 |
2009-07-22 |
Novo Nordisk A/S |
Purification of glucagon-like peptides
|
EP1701969B1
(en)
|
2003-12-31 |
2007-10-24 |
F.Hoffmann-La Roche Ag |
Process for peptide synthesis using a reduced amount of deprotection agent
|
FR2864830B1
(fr)
|
2004-01-06 |
2006-03-10 |
Centre Nat Rech Scient |
Procede de synthese sur support solide de composes peptidiques, notamment de composes peptidiques comportant un residu arginine
|
EP1713723A2
(en)
*
|
2004-01-14 |
2006-10-25 |
William Marsh Rice University |
Fullerene based amino acids
|
EP1718671A2
(en)
|
2004-02-23 |
2006-11-08 |
Rheoscience A/S |
Peptide yy analogues
|
CA2458084A1
(en)
|
2004-03-12 |
2005-09-12 |
Dalton Chemical Laboratories Inc. |
Novel process for octreotide synthesis
|
US7534763B2
(en)
|
2004-07-02 |
2009-05-19 |
Bristol-Myers Squibb Company |
Sustained release GLP-1 receptor modulators
|
TW200611704A
(en)
|
2004-07-02 |
2006-04-16 |
Bristol Myers Squibb Co |
Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions
|
DK1771463T3
(da)
|
2004-07-16 |
2008-04-21 |
Lonza Ag |
Fremgangsmåde til peptidsyntese
|
JP4878031B2
(ja)
|
2004-10-12 |
2012-02-15 |
エフ.ホフマン−ラ ロシュ アーゲー |
固相ペプチド合成法
|
EP1814908A4
(en)
|
2004-11-22 |
2009-07-01 |
Biosight Ltd |
Activated labeling reagents and method for their preparation and use
|
US7745570B2
(en)
|
2004-12-17 |
2010-06-29 |
Kansas State University Research Foundation |
PH dependent adhesive peptides
|
US8716221B2
(en)
|
2005-01-14 |
2014-05-06 |
Wuxi Grandchamp Pharmaceutical Technology Co., Ltd. |
Modified exendins and uses thereof
|
EP1845105A4
(en)
|
2005-01-14 |
2009-02-18 |
Wuxi Grandchamp Pharmaceutical |
MODIFIED EXENDINES AND CORRESPONDING USES
|
JP2008534639A
(ja)
|
2005-04-08 |
2008-08-28 |
ロンザ ア−ゲ− |
Peg樹脂上におけるアルファ−ヘリックスのペプチド合成
|
KR20080012884A
(ko)
|
2005-05-04 |
2008-02-12 |
론자 아게 |
펩타이드 합성 방법
|
CN1298732C
(zh)
|
2005-05-17 |
2007-02-07 |
南京工业大学 |
多肽微波固相合成法
|
PE20061448A1
(es)
|
2005-05-26 |
2006-12-17 |
Bristol Myers Squibb Co |
Compuestos polipeptidos como moduladores del peptido 1 similar al glucagon humano
|
EP1805204A2
(en)
|
2005-09-14 |
2007-07-11 |
Novetide Ltd. |
Process for production of bivalirudin
|
EP1965823B1
(en)
|
2005-11-04 |
2016-05-18 |
Glaxosmithkline LLC |
Methods for administering hypoglycemic agents
|
CN100374462C
(zh)
|
2005-11-21 |
2008-03-12 |
大连帝恩生物工程有限公司 |
截短胰高血糖素样肽1(sGLP-1)、制法及其应用
|
WO2007065691A2
(en)
|
2005-12-07 |
2007-06-14 |
Technische Universität München |
Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins
|
WO2007114454A1
(ja)
|
2006-03-29 |
2007-10-11 |
Otsuka Chemical Co., Ltd. |
ペプチドのチオエステル化合物の製造方法
|
ES2283212B1
(es)
|
2006-03-31 |
2008-08-16 |
Lipotec S.A. |
Peptidos sinteticos utiles en el tratamiento de la piel y su uso en composiciones cosmeticas o dermofarmaceuticas.
|
FI20065208A0
(fi)
|
2006-03-31 |
2006-03-31 |
Karyon Oy |
Peptidikonjugaatteja
|
WO2007113386A1
(en)
|
2006-03-31 |
2007-10-11 |
Karyon-Ctt Ltd |
Peptide conjugates
|
WO2007139589A1
(en)
|
2006-05-26 |
2007-12-06 |
Bristol-Myers Squibb Company |
Sustained release glp-1 receptor modulators
|
GB2440388A
(en)
|
2006-06-30 |
2008-01-30 |
Ucl Biomedica Plc |
Methods of linking a carbohydrate or polyalkylene oxide to a protein, precursors and the resultant products
|
US9766217B2
(en)
|
2006-09-08 |
2017-09-19 |
Novo Nordisk A/S |
Methods of optimizing chromatographic separation of polypeptides
|
WO2008044890A1
(en)
|
2006-10-12 |
2008-04-17 |
Dong Kook Pharm. Co., Ltd |
A method for preparing peptides using by solid phase synthesis
|
ES2322882B1
(es)
|
2006-10-25 |
2010-04-22 |
Lipotec Sa |
Peptidos inhibidores de la exocitosis neuronal.
|
EP1923397B1
(en)
|
2006-11-14 |
2009-10-28 |
NERVIANO MEDICAL SCIENCES S.r.l. |
Fluorinated amino acids and peptides
|
TWI428346B
(zh)
|
2006-12-13 |
2014-03-01 |
Imp Innovations Ltd |
新穎化合物及其等對進食行為影響
|
US7981998B2
(en)
|
2006-12-14 |
2011-07-19 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
EP2094721B1
(en)
|
2006-12-14 |
2018-02-14 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
KR20150116465A
(ko)
|
2007-02-15 |
2015-10-15 |
인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 |
글루카곤/glp-1 수용체 공동-항진물질
|
US20080287650A1
(en)
|
2007-03-01 |
2008-11-20 |
Avi Tovi |
High purity peptides
|
WO2008137165A1
(en)
|
2007-05-07 |
2008-11-13 |
President And Fellows Of Harvard College |
Anti-glycated cd59 antibodies and uses thereof
|
ATE520714T1
(de)
|
2007-06-15 |
2011-09-15 |
Zealand Pharma As |
Glucagonanaloga
|
JP2010531828A
(ja)
|
2007-06-29 |
2010-09-30 |
ロンザ アーゲー |
プラムリンチドの製造方法
|
CN101357938B
(zh)
|
2007-07-31 |
2013-07-03 |
周逸明 |
固相多肽合成Exenatide的制备方法
|
CN101357937B
(zh)
|
2007-07-31 |
2012-11-07 |
上海苏豪逸明制药有限公司 |
固相多肽合成阿托西般的制备方法
|
WO2009059002A2
(en)
*
|
2007-10-30 |
2009-05-07 |
The Regents Of The University Of Michigan Office Of Technology Transfer |
Macrocyclization of compounds from solid support using thioesterases
|
MX2010006044A
(es)
|
2007-12-11 |
2010-06-23 |
Hoffmann La Roche |
Sintesis de peptidos insulinotropicos utilizando una combinacion de tecnicas en fase solida y en solucion.
|
KR101257330B1
(ko)
|
2008-02-06 |
2013-04-23 |
바이오콘 리미티드 |
펩타이드 정제 방법
|
ES2330291B1
(es)
|
2008-02-29 |
2010-10-18 |
Lipotec Sa |
Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
|
CN101525370A
(zh)
|
2008-03-06 |
2009-09-09 |
海南建邦制药科技有限公司 |
一种新型高效多肽合成缩合剂
|
CN101525368B
(zh)
|
2008-03-06 |
2012-05-30 |
海南建邦制药科技有限公司 |
一种多肽合成脱保护剂
|
CN101255191A
(zh)
|
2008-03-12 |
2008-09-03 |
中国药科大学 |
微波促进固相合成胰高血糖素样肽-1(glp-1)类似物及其应用
|
WO2009132231A2
(en)
|
2008-04-24 |
2009-10-29 |
Therimunex Pharmaceuticals, Inc. |
Peptidyl diacylglycerides
|
US20120149868A1
(en)
|
2008-05-15 |
2012-06-14 |
Novo Nordisk A/S |
Purification of peptides prepared by solid phase synthesis
|
BRPI0915282A2
(pt)
|
2008-06-17 |
2017-02-07 |
Univ Indiana Res & Tech Corp |
agonistas mistos baseados no gip para o tratamento de distúrbios metabólicos e obesidade
|
JP5775450B2
(ja)
|
2008-06-17 |
2015-09-09 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
グルカゴン/glp−1受容体コアゴニスト
|
TWI395752B
(zh)
|
2008-09-03 |
2013-05-11 |
Scinopharm Taiwan Ltd |
製造比伐蘆汀(bivalirudin)之方法
|
TW201012829A
(en)
|
2008-09-22 |
2010-04-01 |
Ipsen Mfg Ireland Ltd |
Process for the synthesis of (Aib8,35)hGLP-1(7-36)-NH2
|
AU2009294875C1
(en)
|
2008-09-22 |
2015-05-14 |
Aileron Therapeutics, Inc. |
Methods for preparing purified polypeptide compositions
|
CA2745499A1
(en)
|
2008-12-05 |
2010-06-10 |
Angiochem Inc. |
Peptide therapeutic conjugates and uses thereof
|
MX2011005963A
(es)
|
2008-12-05 |
2011-09-01 |
Angiochem Inc |
Conjugados de neurotensina o analogos de neurotensina y sus usos.
|
BRPI0922691A2
(pt)
|
2008-12-05 |
2018-11-06 |
Angiochem Inc |
conjugados de leptina e análogo de leptina e usos dos mesmos
|
ES2439499T3
(es)
|
2008-12-15 |
2014-01-23 |
Zealand Pharma A/S |
Análogos de glucagón
|
CN102282167B
(zh)
|
2008-12-15 |
2014-08-13 |
西兰制药公司 |
胰高血糖素类似物
|
CA2747112A1
(en)
|
2008-12-15 |
2010-06-24 |
Zealand Pharma A/S |
Glucagon analogues
|
NZ593813A
(en)
|
2008-12-15 |
2013-02-22 |
Zealand Pharma As |
Glucagon analogues
|
CN101463081B
(zh)
|
2009-01-12 |
2012-07-04 |
华东师范大学 |
一种glp-1衍生物
|
CN101463078B
(zh)
|
2009-01-12 |
2011-07-27 |
华东师范大学 |
一种Exendin-4衍生物及其固相化学合成
|
CN101538324B
(zh)
|
2009-01-13 |
2013-01-16 |
深圳翰宇药业股份有限公司 |
一种制备艾塞那肽的方法
|
ES2349972B1
(es)
|
2009-02-16 |
2011-11-24 |
Lipotec, S.A. |
Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosméticas o farmacéuticas.
|
WO2010096052A1
(en)
|
2009-02-19 |
2010-08-26 |
Merck Sharp & Dohme Corp. |
Oxyntomodulin analogs
|
MX337830B
(es)
|
2009-04-17 |
2016-03-16 |
Lipotec Sa |
Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
|
CN101555274B
(zh)
|
2009-05-15 |
2013-08-21 |
海南双成药业股份有限公司 |
一种多肽固相合成比法卢定粗品的制备方法
|
IN2012DN00377A
(es)
|
2009-06-16 |
2015-08-21 |
Univ Indiana Res & Tech Corp |
|
NZ597981A
(en)
|
2009-07-13 |
2014-02-28 |
Zealand Pharma As |
Acylated glucagon analogues
|
CA2768386A1
(en)
|
2009-07-24 |
2011-01-27 |
Lipotec, S.A. |
Compounds which inhibit muscle contraction
|
ES2358829B1
(es)
|
2009-10-23 |
2012-06-25 |
Lipotec, S.A. |
Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cabello y su uso en composiciones cosméticas o farmacéuticas.
|
US8703701B2
(en)
|
2009-12-18 |
2014-04-22 |
Indiana University Research And Technology Corporation |
Glucagon/GLP-1 receptor co-agonists
|
EP2528618A4
(en)
|
2010-01-27 |
2015-05-27 |
Univ Indiana Res & Tech Corp |
GLUCAGON ANTAGONISTE AND GIP AGONISTS CONJUGATES AND COMPOSITIONS FOR THE TREATMENT OF METABOLISM DISEASES AND ADIPOSITAS
|
EP2542565A1
(en)
|
2010-03-01 |
2013-01-09 |
Novo Nordisk A/S |
Preparative rp-hplc method for purifying peptides
|
CA2792663A1
(en)
|
2010-03-26 |
2011-09-29 |
Novo Nordisk A/S |
Novel glucagon analogues
|
US8620595B2
(en)
|
2010-03-26 |
2013-12-31 |
University Of Manitoba |
Methods for determining the retention of peptides in reverse phase chromatography using linear solvent strength theory
|
AR080592A1
(es)
|
2010-03-26 |
2012-04-18 |
Lilly Co Eli |
Peptido con actividad para el gip-r y glp-1-r, formulacion famaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de diabetes mellitus y para inducir la perdida de peso
|
CN102918177B
(zh)
|
2010-05-31 |
2015-09-09 |
株式会社捷太格特 |
覆盖部件的制造方法
|
EP2579435B1
(en)
|
2010-06-01 |
2016-11-30 |
Honda Motor Co., Ltd. |
Controller for dc/dc converter
|
US20110313131A1
(en)
|
2010-06-21 |
2011-12-22 |
Christelle Carl |
Reversed phase hplc purification of a glp-1 analogue
|
AR081975A1
(es)
|
2010-06-23 |
2012-10-31 |
Zealand Pharma As |
Analogos de glucagon
|
CN101906150B
(zh)
|
2010-06-28 |
2013-01-09 |
上海昂博生物技术有限公司 |
一种比法卢定的制备方法
|
WO2012057624A1
(en)
|
2010-10-25 |
2012-05-03 |
Pepscan Systems B.V. |
Novel bicyclic peptide mimetics
|
CN103189384A
(zh)
|
2010-10-29 |
2013-07-03 |
隆萨有限公司 |
形成二酮哌嗪的二肽连接子
|
SG191194A1
(en)
|
2010-12-22 |
2013-07-31 |
Univ Indiana Res & Tech Corp |
Glucagon analogs exhibiting gip receptor activity
|
EP2655395B1
(en)
|
2010-12-23 |
2018-03-07 |
Universiteit Gent |
Method for cross-linking peptides
|
CN102643339B
(zh)
|
2011-02-21 |
2014-04-09 |
天津药物研究院 |
一种glp-1类似物、制备方法及其应用
|
CN102174082B
(zh)
|
2011-02-23 |
2014-08-27 |
上海昂博生物技术有限公司 |
一种艾塞那肽的制备方法
|
ES2397889B1
(es)
|
2011-03-25 |
2014-02-07 |
Lipotec, S.A. |
PÉPTIDOS MODULADORES DE PGC-1Alfa.
|
CN102718858B
(zh)
|
2011-03-29 |
2014-07-02 |
天津药物研究院 |
胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用
|
EP2694095B1
(en)
|
2011-04-05 |
2018-03-07 |
Longevity Biotech, Inc. |
Compositions comprising glucagon analogs and methods of making and using the same
|
CN102786590A
(zh)
|
2011-05-19 |
2012-11-21 |
江苏豪森药业股份有限公司 |
分枝型peg修饰的glp-1类似物及其可药用盐
|
US8933196B2
(en)
|
2011-05-20 |
2015-01-13 |
National Central University |
Peptide chromatographic purification assisted by combining of solubility parameter and solution conformation energy calculations
|
CN102286076B
(zh)
|
2011-06-23 |
2014-03-12 |
成都圣诺科技发展有限公司 |
比伐卢定的制备方法
|
CN102286092B
(zh)
|
2011-09-14 |
2014-01-01 |
深圳翰宇药业股份有限公司 |
利拉鲁肽的固相合成方法
|
NL2007536C2
(en)
|
2011-10-05 |
2013-04-08 |
Academisch Ziekenhuis Leiden Lumc |
Adjuvant compound.
|
RU2625793C2
(ru)
|
2011-12-23 |
2017-07-19 |
Ипсен Мэньюфэкчеринг Айэлэнд Лимитед |
Способ синтеза терапевтических пептидов
|
CN102411801A
(zh)
|
2011-12-27 |
2012-04-11 |
湖南超氏信息集成有限公司 |
一种挂起排队方法
|
CN102584944B
(zh)
|
2012-02-06 |
2014-12-17 |
成都圣诺生物科技股份有限公司 |
一种依非巴特的制备方法
|
CN103242443A
(zh)
|
2012-02-06 |
2013-08-14 |
长春百克生物科技股份公司 |
一种胸腺素α1及其类似物的制备方法
|
CN102584982B
(zh)
|
2012-02-10 |
2014-02-05 |
深圳翰宇药业股份有限公司 |
一种纯化固相合成利拉鲁肽粗肽的方法
|
CN102558338B
(zh)
|
2012-02-10 |
2014-09-17 |
深圳翰宇药业股份有限公司 |
一种合成利西拉来的方法
|
BR112014025621B1
(pt)
|
2012-04-16 |
2023-01-17 |
Lubrizol Advanced Materials, Inc |
Composto, composição cosmética ou farmacêutica, e, uso de um composto
|
US20130289241A1
(en)
|
2012-04-26 |
2013-10-31 |
Shanghai Ambiopharm, Inc. |
Method for preparing exenatide
|
AU2013262069C1
(en)
|
2012-05-16 |
2019-01-31 |
Aptarion Biotech Ag |
Enzymatic synthesis of L-nucleic acids
|
CN102875663B
(zh)
|
2012-09-26 |
2014-06-11 |
深圳翰宇药业股份有限公司 |
利西拉来的纯化方法
|
CN104994924B
(zh)
|
2013-01-29 |
2017-09-22 |
诺伊兰健康科学私人有限公司 |
使用在反相柱上的替代固定相纯化有机化合物
|
CN103965285B
(zh)
|
2013-02-06 |
2016-12-28 |
北京大学 |
一种以超顺磁纳米颗粒为固相进行多肽合成及同步构建多肽磁纳米探针的方法
|
CN103333237B
(zh)
|
2013-05-07 |
2015-03-11 |
海南双成药业股份有限公司 |
一种固相片段法合成艾塞那肽
|
JP2016527231A
(ja)
|
2013-07-15 |
2016-09-08 |
ノース カロライナ ステイト ユニヴァーシティ |
プロテアーゼ耐性ペプチドリガンド
|
US9263194B2
(en)
|
2013-09-06 |
2016-02-16 |
Gwangju Institute Of Science And Technology |
Porphyrin-peptoid conjugate and the preparation process thereof
|
WO2015038919A1
(en)
|
2013-09-15 |
2015-03-19 |
Stc. Unm |
Method for atomic layer deposition
|
CN103536912B
(zh)
|
2013-09-30 |
2015-05-13 |
重庆理工大学 |
一种猪圆环病毒2型表位肽疫苗及其制备方法
|
CN103613655B
(zh)
|
2013-11-20 |
2015-05-13 |
陕西东大生化科技有限责任公司 |
一种低成本纯化艾塞那肽的方法
|
BR112016012391A2
(pt)
|
2013-12-01 |
2017-09-26 |
Univ Copenhagen |
composto, e, método para fabricar o composto
|
HU230584B1
(hu)
|
2014-02-28 |
2017-01-30 |
Szegedi Tudományegyetem |
Eljárás peptidek előállítására
|
CN104086631A
(zh)
|
2014-07-10 |
2014-10-08 |
成都天台山制药有限公司 |
卡贝缩宫素和制法
|
RU2696276C2
(ru)
|
2014-08-07 |
2019-08-01 |
Ф. Хоффманн-Ля Рош Аг |
Способы получения аналогов окситоцина
|
US9688750B2
(en)
|
2014-10-07 |
2017-06-27 |
Ann And Robert H. Lurie Children's Hospital Of Chicago |
Anti-nodal antibodies and methods of using same
|
CN105585612B
(zh)
|
2014-10-20 |
2020-05-05 |
北京益生康华医药技术有限公司 |
八肽修饰的地塞米松、制备、纳米结构和应用
|
US10344069B2
(en)
|
2014-10-31 |
2019-07-09 |
Auro Peptides Ltd. |
Process for the preparation of liraglutide
|
WO2016084100A2
(en)
|
2014-11-26 |
2016-06-02 |
Alaparthi Lakshmi Prasad |
Novel and efficient method for large scale synthesis of romidepsin
|
US10308677B2
(en)
|
2014-12-19 |
2019-06-04 |
Cem Corporation |
Coupling method for peptide synthesis at elevated temperatures
|
CN105111303B
(zh)
|
2015-06-23 |
2019-07-26 |
济南康和医药科技有限公司 |
一种固液结合制备利拉鲁肽的方法
|
CA3018627A1
(en)
|
2016-03-23 |
2017-09-28 |
Bachem Holding Ag |
Purification of glucagon-like peptide 1 analogs
|